StockNews.com assumed coverage on shares of InVivo Therapeutics (NASDAQ:NVIV – Free Report) in a research report report published on Wednesday morning. The brokerage issued a sell rating on the biotechnology company’s stock. InVivo Therapeutics Price Performance Shares of NASDAQ:NVIV opened at $0.78 on Wednesday. InVivo Therapeutics has a 52-week low of $0.60 and a 52-week […]
StockNews.com initiated coverage on shares of InVivo Therapeutics (NASDAQ:NVIV – Free Report) in a research note published on Tuesday morning. The brokerage issued a sell rating on the biotechnology company’s stock. InVivo Therapeutics Price Performance NASDAQ:NVIV opened at $0.73 on Tuesday. The firm has a 50 day simple moving average of $0.78 and a 200-day […]
StockNews.com initiated coverage on shares of InVivo Therapeutics (NASDAQ:NVIV – Free Report) in a research report report published on Tuesday. The firm issued a sell rating on the biotechnology company’s stock. InVivo Therapeutics Stock Performance NVIV opened at $0.78 on Tuesday. InVivo Therapeutics has a 52 week low of $0.60 and a 52 week high […]
StockNews.com assumed coverage on shares of InVivo Therapeutics (NASDAQ:NVIV – Free Report) in a research report released on Tuesday. The firm issued a sell rating on the biotechnology company’s stock. InVivo Therapeutics Price Performance NVIV opened at $0.78 on Tuesday. InVivo Therapeutics has a 12-month low of $0.60 and a 12-month high of $2.80. The […]
StockNews.com began coverage on shares of InVivo Therapeutics (NASDAQ:NVIV – Free Report) in a research note published on Monday morning. The firm issued a sell rating on the biotechnology company’s stock. InVivo Therapeutics Trading Down 7.0 % NVIV stock opened at $0.74 on Monday. InVivo Therapeutics has a 12-month low of $0.60 and a 12-month […]